Cancer immunotherapy in 2017: The breakthrough of the microbiota

Nature Reviews Immunology 18, 87 (2018). doi:10.1038/nri.2018.4 Authors: Guido Kroemer & Laurence Zitvogel In 2017, epidemiological studies in humans and experiments in mouse models showed that the intestinal microbiota determines the effectiveness of anticancer immunotherapies. As such the microbiota offers new prognostic biomarkers and shows promise as a target for future antineoplastic treatments.
Source: Nature Reviews Immunology - Category: Allergy & Immunology Authors: Tags: Year in Review Source Type: research